Literature DB >> 16752141

Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.

M Besson1, V David, S Suarez, A Cormier, P Cazala, J-P Changeux, S Granon.   

Abstract

RATIONALE: Nicotine addiction is characterized by two distinct behaviors, chronic compulsive self-administration and the induction of a withdrawal syndrome upon cessation of nicotine consumption.
OBJECTIVE: To examine if these two processes rely on beta2-containing nicotinic receptors--beta2*nAChRs--we analyzed the behavior of mice lacking these receptors in the two situations.
RESULTS: First, we showed that, in contrast to wild-type (WT) mice, beta2-knockout (beta2-/-) mice exhibit no intra-ventral tegmental area (VTA) nicotine self-administration, whereas their ability to self-administer morphine is intact. However, beta2-/- mice showed some sensitivity to locomotor effects of nicotine, implying an effect of the drug on other nicotinic subtypes. Then, we observed that beta2-/- mice exhibited a normal nicotine withdrawal syndrome, i.e., increased levels of rearing and jumping upon precipitated withdrawal. Thus, the beta2*nAChRs are not involved in the behaviors induced by cessation of nicotine consumption.
CONCLUSION: Taken together, the present data demonstrated a genetic dissociation of two distinct behavioral patterns associated with nicotine addiction. They further suggested that independent molecular mechanisms underlie these two aspects, offering the possibility of controlling them separately.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16752141     DOI: 10.1007/s00213-006-0418-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

Review 1.  Localization of drug reward mechanisms by intracranial injections.

Authors:  R A Wise; D C Hoffman
Journal:  Synapse       Date:  1992-03       Impact factor: 2.562

2.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

3.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

4.  Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

Authors:  A Castañé; E Valjent; C Ledent; M Parmentier; R Maldonado; O Valverde
Journal:  Neuropharmacology       Date:  2002-10       Impact factor: 5.250

Review 5.  Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness.

Authors:  G G Nomikos; B Schilström; B E Hildebrand; G Panagis; J Grenhoff; T H Svensson
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

6.  Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.

Authors:  B E Hildebrand; G G Nomikos; C Bondjers; M Nisell; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

7.  Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.

Authors:  Jacques Barik; Susan Wonnacott
Journal:  Mol Pharmacol       Date:  2005-11-03       Impact factor: 4.436

8.  Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype.

Authors:  Sheri D Grabus; Billy R Martin; M Imad Damaj
Journal:  Eur J Pharmacol       Date:  2005-05-16       Impact factor: 4.432

9.  Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.

Authors:  M I Damaj; W Kao; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  2003-09-11       Impact factor: 4.030

10.  Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.

Authors:  M A Russell; M Jarvis; R Iyer; C Feyerabend
Journal:  Br Med J       Date:  1980-04-05
View more
  35 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

3.  Long-term effects of chronic nicotine exposure on brain nicotinic receptors.

Authors:  Morgane Besson; Sylvie Granon; Monica Mameli-Engvall; Isabelle Cloëz-Tayarani; Nicolas Maubourguet; Anne Cormier; Pierre Cazala; Vincent David; Jean-Pierre Changeux; Philippe Faure
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

Review 4.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Nicotine analog inhibition of nicotine self-administration in rats.

Authors:  Neil E Rowland; Kimberly Robertson; Ferenc Soti; William R Kem
Journal:  Psychopharmacology (Berl)       Date:  2008-06-07       Impact factor: 4.530

6.  Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.

Authors:  Irene Morganstern; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Jane Shaji; Olga Karatayev; Sarah F Leibowitz
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

7.  Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Authors:  John A Dani; Mariella De Biasi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

8.  The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.

Authors:  K J Jackson; J M McIntosh; D H Brunzell; S S Sanjakdar; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2009-07-30       Impact factor: 4.030

9.  Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: a BOLD fMRI study.

Authors:  S V Suarez; A Amadon; E Giacomini; A Wiklund; J-P Changeux; D Le Bihan; S Granon
Journal:  Psychopharmacology (Berl)       Date:  2008-09-26       Impact factor: 4.530

Review 10.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.